Ceritinib and Ethosuximide Syrup
Determining the interaction of Ceritinib and Ethosuximide Syrup and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration with ceritinib may increase the plasma concentrations of drugs that are primarily metabolized by CYP450 2C9 and/or 3A4. In vitro data suggest that ceritinib may inhibit these isoenzymes at clinical concentrations. In vivo pharmacokinetic data are not available. MANAGEMENT: Concomitant use of ceritinib and sensitive CYP450 2C9/3A4 substrates or substrates with narrow therapeutic ranges should generally be avoided. These drugs include alfentanil, colchicine, cyclosporine, ergot derivatives, fentanyl, lovastatin, simvastatin, oral midazolam, triazolam, phenytoin, pimozide, quinidine, sildenafil, sirolimus, tacrolimus, and warfarin. If coadministration is required, dosage reductions for the CYP450 2C9 or 3A4 substrates should be considered. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Zykadia (ceritinib)." Novartis Pharmaceuticals, East Hanover, NJ.
Professional:GENERALLY AVOID: Coadministration with ceritinib may increase the plasma concentrations of drugs that are primarily metabolized by CYP450 2C9 and/or 3A4. In vitro data suggest that ceritinib may inhibit these isoenzymes at clinical concentrations. In vivo pharmacokinetic data are not available.
MANAGEMENT: Concomitant use of ceritinib and sensitive CYP450 2C9/3A4 substrates or substrates with narrow therapeutic ranges should generally be avoided. These drugs include alfentanil, colchicine, cyclosporine, ergot derivatives, fentanyl, lovastatin, simvastatin, oral midazolam, triazolam, phenytoin, pimozide, quinidine, sildenafil, sirolimus, tacrolimus, and warfarin. If coadministration is required, dosage reductions for the CYP450 2C9 or 3A4 substrates should be considered.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Zykadia (ceritinib)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: ethosuximide
Brand name: Zarontin
Synonyms: Ethosuximide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ceritinib-Ethotoin
- Ceritinib-Ethynodiol diacetate and Ethinyl Estradiol
- Ceritinib-Ethyol
- Ceritinib-Etidronate
- Ceritinib-Etidronate Disodium
- Ceritinib-Etidronate Oral, Intravenous
- Ethosuximide Syrup-Cerovite Jr
- Ethosuximide Syrup-Certolizumab
- Ethosuximide Syrup-Certolizumab Pegol
- Ethosuximide Syrup-Certolizumab Prefilled Syringes
- Ethosuximide Syrup-Certolizumab Subcutaneous
- Ethosuximide Syrup-Certolizumab Vials